Insulet Corporation - Common Stock (NQ:PODD)

Comments from Insulet's CEO at a major healthcare conference rattled investors.

14 Analysts Have This to Say About Insulet ↗

September 29, 2023

Via Benzinga

Why Insulet Stock Is Sinking Today ↗

September 07, 2023

The broad-market index is up but these stocks are down.

Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year? ↗

September 29, 2023

Topics Stocks

Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023

September 28, 2023

September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average ↗

September 27, 2023

The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months.

Via Benzinga

Topics Stocks

Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside ↗

September 24, 2023

In the middle of the AI revolution and the Federal Reserve's steadfast stance on interest rates, the stock market has seen unexpected twists and turns. Despite hopes of the U.S.

Via Benzinga

Topics Artificial Intelligence Stocks

What 12 Analyst Ratings Have To Say About Insulet ↗

September 06, 2023

Via Benzinga

What 8 Analyst Ratings Have To Say About Insulet ↗

August 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

The 7 Most Undervalued Stocks in the Market Right Now: September 2023 ↗

September 15, 2023

Buying these undervalued stocks right now can pay off tremendously once these fundamentally solid businesses ultimately recover.

Via InvestorPlace

Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch ↗

September 15, 2023

Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood...

Via Benzinga

Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks? ↗

September 07, 2023

The S&P 500 had a rare decline last month.

Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar ↗

Topics Stocks

September 06, 2023

Dexcom says the popularity of GLP-1 drugs won't hurt its continuous glucose monitors.

Via Investor's Business Daily

The 3 Most Promising Healthcare Stocks to Own Now ↗

September 01, 2023

These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

September 15, 2023

Friday's session saw 169 companies set new 52-week lows.

Via Benzinga

Why Insulet Stock Rocked the Market Today ↗

August 30, 2023

The company's leader signals a giant vote of confidence in its future.

Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday ↗

August 30, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 07, 2023

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for...

Via Benzinga

$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying ↗

August 30, 2023

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 29, 2023

On Tuesday, 99 stocks hit new 52-week lows.

Via Benzinga

Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany

August 28, 2023

Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know ↗

August 24, 2023

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 24, 2023

Credit Suisse lowered the price target for The Walt Disney Company (NYSE: DIS) from $126 to $122. Credit Suisse analyst Douglas Mitchelson maintained an Outperforn rating. Disney shares gained 0.4% to...

Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 ↗

August 21, 2023

Via Benzinga

NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday ↗

August 21, 2023

Via Benzinga

JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth ↗

August 17, 2023

J.P.

Via Benzinga

Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)

August 08, 2023